Silvercrest Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Silvercrest Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-223,840	Closed	-$5.3M	–	849
2021 Q1	$5.3M	Sell	223,840 -29,744	-12%	-$707K	0.04%	373
2020 Q4	$5.08M	Sell	253,584 -43,131	-15%	-$842K	0.04%	362
2020 Q3	$6.18M	Sell	296,715 -5,584	-2%	-$101K	0.05%	298
2020 Q2	$5.29M	Sell	302,299 -5,294	-2%	-$104K	0.05%	302
2020 Q1	$5.02M	Buy	307,593 +51,752	+20%	+$1.07M	0.05%	271
2019 Q4	$5.26M	Sell	255,841 -191,857	-43%	-$3.2M	0.04%	337
2019 Q3	$5.14M	Buy	+447,698	New	+$5.11M	0.04%	330

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Silvercrest Asset Management's COLL Position: Q2 2021 in Review

Silvercrest Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2021, closing a stake of 223,840 shares — an estimated $5.3M sold.

Silvercrest Asset Management first reported a position in COLL in Q3 2019 and held it in 7 quarters. The position peaked at $6.18M in Q3 2020. 158 funds tracked by Wall St. Rank hold COLL as of Q2 2021.

Silvercrest Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Silvercrest Asset Management sold 223,840 Collegium Pharmaceutical shares in Q2 2021, an estimated $5.3M.
Silvercrest Asset Management first reported a position in Collegium Pharmaceutical in Q3 2019 and held it in 7 quarters.
Silvercrest Asset Management's Collegium Pharmaceutical position peaked at $6.18M in Q3 2020.
158 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2021.

Based on Silvercrest Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.